Serum testosterone levels and breast cancer recurrence

Area of Science:

• Endocrinology
• Oncology
• Cancer Research

Background:

• Elevated serum androgens and estrogens are linked to increased postmenopausal breast cancer incidence.
• Understanding the prognostic value of hormones in breast cancer patients is crucial for personalized treatment.

Purpose of the Study:

• To investigate the prognostic significance of serum testosterone, estradiol, and related factors in postmenopausal breast cancer patients.
• To determine if hormone levels predict recurrence risk in breast cancer survivors.

Main Methods:

• Prospective study of 110 postmenopausal breast cancer patients without clinical recurrence.
• Follow-up for 5.5 years to monitor distant metastasis, local relapse, or contralateral breast cancer.
• Cox's proportional hazard modeling used to assess risk related to hormone levels, adjusting for clinical factors.

Main Results:

• Patients who recurred had significantly higher body mass index, testosterone, estradiol, and glucose levels.
• High baseline testosterone levels were strongly associated with increased breast cancer recurrence risk (HR 7.2 for upper tertile).
• Testosterone demonstrated a more significant impact on prognosis compared to other hormones studied.

Conclusions:

• Elevated serum testosterone is a significant predictor of breast cancer recurrence in postmenopausal women.
• Further investigation into testosterone-lowering interventions, such as dietary or medical approaches, is warranted.
• These findings may inform future strategies for managing breast cancer recurrence risk.